Abstract
The future of aging and human life extension begins today, using presently available tools, but will be increasingly shaped and accelerated by ongoing breakthroughs in biotechnology, nanotechnology and artificial intelligence in the years ahead. These developing technologies should allow many to journey over what can be seen as three bridges to ever-improving life and health expectancy, such that some who survive as a result of “bridge one” may be able to benefit from “bridge two” and even from “bridge three.” We begin our perspective on the future of aging with a brief overview of a sampling of present approaches to life extension (“bridge one”) and then explain why biotechnology (“bridge two”) and nanotechnology plus artificial intelligence (“bridge three”) might allow many of us to benefit from remarkably extended lifespans in the future.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
American College of Sports Medicine, ed. (2010) ACSM’s Resource manual for Guidelines for Exercise Testing and Prescription, Lippincott, Williams and Wilkins: Philadelphia, pp. 346–347, 513–514
Ames BN, Elson-Schwab I, Silver EA (2002) High-dose vitamin therapy stimulates variant enzymes with decreased coenzyme binding affinity (increased Km): relevance to genetic disease and polymorphisms. Am J Clin Nutr 75:616–658
Ames BN, Wakimoto P (2002) Are vitamin and mineral deficiencies a major cancer risk? Nat Rev Cancer 2:694–704
Angier N. Diet offers tantalizing clues to a long life. New York Times, April 17, 1990, sec. C
Barger JL, Kayo T, Pugh TD, Prolla TA, Weindruch R (2008) Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Exp Gerontol 43:859–866
Baur JA, Pearson KJ, Price, NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair, DA (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444:337–342
Berger TW, Ahuja A, Courellis SH, Deadwyler SA, Erinjippurath G, Gerhardt GA, Gholmieh G, Granacki JJ, Hampson R, Hasio MC, Lacoss J, Marmarelis VZ, Nasiatka P, Srinivasan V, Song D, Tanguay AR, Wills J (2005) Restoring lost cognitive function: hippocampal-cortical neural prostheses. IEEE Eng Med Biol 24:30–44
Blair SN, Kohl HW 3rd, Barlow CE, Gibbons LW (1989) Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 262:2395–2401
Blüher M, Kahn BB, Kahn CR (2003) Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 299:572–574
Botto LD, Yang Q (2000) 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol 151:862–877
Cadieu C, Kouh M, Pasupathy A, Connor C, Riesenhuber M, Poggio T (2007) A model of V4 shape selectivity and invariance. J Neurophysiol 98:1733–1750
Cerami A (1985) Hypothesis: glucose as a mediator of aging. J Am Geriatr Soc 33:626–634
Church TS, Earnest CP, Wood KA, Kampert JB (2003) Reduction of C-reactive protein levels through use of a multivitamin. Am J Med 15(115):702–707
Davies K (2007) Computational Biology: Project Jim: Watson’s Genome Goes Public: 454 Baylor Scientists Present Jim Watson with His Personal Genome, Flaws, and All. BioIT-World, 6:5,16
Desai TA (2003) MEMS-based technologies for cellular encapsulation: focus on nanopore biocapsules for diabetes mellitus therapy. Am J Drug Deliv 1:3–11
Deschenes MR (2004) Effects of aging on muscle fibre type and size. Sports Med 34:809–824
Dhahbi JM, Mote PL, Fahy GM, Spindler SR (2005) Identification of potential calorie restriction mimetics by microarray profiling. Physiol Genomics 23:343–350
Dobson A, DaVanzo J, Consunji M, Gilani J, McMahon P, Sen N, Preston B (2004) A Study of the Cost Effects of Daily Multivitamins for Older Adults. The Lewin Group: Falls Church.
Duncan, DE (2002) DNA as destiny. Wired 10:183
Eto M, Watanabe K, Chonan N, Ishii K (1988) Familial hypercholesterolemia and apolipoprotein E4. Atherosclerosis. 72:123–128
Facchini A, Haaijman JJ, Labo G (eds) (1986) Immunoregulation in Aging. EURAGE: Rijswijk 53–61
Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer’s disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 278:1349–1356
Ferrari CK, Torres EA (2003) Biochemical pharmacology of functional foods and prevention of chronic diseases of aging. Biomed Pharmacother 57:251–260
Friedman DA, Lukiw WJ, Hill JM (2007) Apolipoprotein E ɛ4 Offers Protection Against Age-Related Macular Degeneration. Med Hypotheses 68(5):1047–1055
Hamdi HK, Keney C (2003) Age-Related Macular Degeneration: A New Viewpoint. Frontiers in Bioscience 8:e305–e314
Harrison SA, Ramrakhiani S, Brunt EM, Anbari MA, Cortese C, Bacon BR (2003) Orlistat in the treatment of NASH: a case series. Am J Gastroenterol 98:926–930
Hursting SD, Lavigne JA, Berrigan D, Perkins SN, Barrett JC (2003) Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Ann Rev Med 54:131–152
Kahn C (1990) His theory is simple: eat less, live longer. A lot longer. Longevity 2 [Oct]:60–62, 64, 66
Kamboh R (1995) Apolipoprotein E polymorphism and susceptibility to Alzheimer’s disease. Hum Biol 67:195–215
Kardaun JW, White L, Resnick HE, Petrovitch H, Marcovina SM, Saunders AM, Foley DJ, Havlik RJ (2000) Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in the Honolulu-Asia aging study. Clin Chem 46:1548–1554
Koizumi A, Weindruch R, Walford RL (1987) Influences of dietary restriction and age on liver enzyme activities and lipid peroxidation in mice. J Nutr 117:361–367
Kris-Etherton PM, Harris WS, Appel LJ for the Nutrition Committee (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106:2747–2757
Kurzweil R (2005) The Singularity is Near: When Humans Transcend Biology. Viking, New York, pp. 491–496
Kurzweil R, Grossman T (2004) Fantastic Voyage: Live Long Enough To Live Forever. Rodale, New York
Kurzweil R, Grossman T (2009) Transcend: Nine Steps to Living Well Forever. Rodale, New York
Lancaster JM (1997) BRCA 1 and 2—A Genetic Link to Familial Breast and Ovarian Cancer. Medscape Women’s Health 2: 7
Lane MA, Mattison J, Ingram DK, Roth GS (2002) Caloric restriction and aging in primates: relevance to humans and possible CR mimetics. Microsc Res Tech 59:335–338
Lee IM (2003) Physical activity in women: how much is good enough? JAMA 290:1377–1378
Lee JKT, Sagel SS, Stanley RJ, Heiken JP (2005) Computed Body Tomography with MRI Correlation, 2nd Ed. Lippincott Williams & Wilkins, New York
Li X, Du Y, Huang X (2003) Association of apoliproprotein E gene polymorphism with essential hypertension and its complications. Clin Exp Med 2:175–179
Licastro F, Weindruch R, Davis LJ, Walford RL (1988) Effect of dietary restriction upon the age-associated decline of lymphocyte DNA repair activity in mice. AGE 11:48–52
Liem AH, Jukema JW, van Veldhuisen DJ (2003) Secondary prevention in coronary heart disease patients with low HDL: what options do we have? Int J Cardiol 90:15–21
Markram H (2006) The blue brain project. Nat Rev Neurosci 7:153–160
McGinnis JM, Foege WH (1993) Actual causes of death in the United States. JAMA 270:207–212
Medina JF, Garcia KS, Nores WL, Taylor NM, Mauk MD (2000) Timing mechanisms in the cerebellum: testing predictions of a large-scale computer simulation. J Neurosci 20: 5516–5525
Myers RH, Schaefer EJ, Wilson PW, D’Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA (1996) Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology 46:673–677
Prescott JH, Lipka S, Baldwin S, Sheppard NF Jr, Maloney JM, Coppeta J, Yomtov B, Staples MA, Santini JT Jr (2006) Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device. Nat Biotechnol 24:437–438
Reiser MF, Becker CR, Nikolaou K, Glazer G (2008) Multislice CT. Springer, Berlin, Heidelberg, New York
Retz W, Gsell W, Munch G, Rosler M, Riederer P (1998) Free radicals in Alzheimer’s disease. J Neural Transm Suppl 54:221–236
Riesenhuber M, Poggio T (2002) Neural mechanisms of object recognition. Curr Opin Neurobiol 12:162–168
Robitaille P-MLAM, Abduljalil AM, Kangarlu A (2000) Ultra high resolution imaging of the human head at 8 Tesla: 2 K × 2 K for Y2K. J Comp Assist Tomogr 24:2–8
Sando SB, Melquist S, Cannon A, Hutton ML, Sletvold O, Saltvedt I, White LR, Lydersen S, Aasly JO (2008) APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer’s disease; a case control study from central Norway. BMC Neurol Apr 16;8:9
Singh PP, Singh M, Mastana SS (2002) Genetic variation of apolipoproteins in North Indians. Hum Biol 74:673–682
Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55: 964–968
Trajtenberg M (1990) Economic Analysis of Product Innovation: The Case of CT Scanners. Harvard University Press, Cambridge
Watts L (2003) Visualizing complexity in the brain. In: Fogel D, Robinson C, (eds) Computational Intelligence: The Experts Speak. IEEE Press/Wiley, Hoboken, pp. 45–56; http://www.lloydwatts.com/wcci.pdf
Wheeler DA, Srinivasan M, Egholm M, Shen Y, Chen L, McGuire A, He W, Chen YJ, Makhijani V, Roth GT, Gomes X, Tartaro K, Niazi F, Turcotte CL, Irzyk GP, Lupski JR, Chinault C, Song XZ, Liu Y, Yuan Y, Nazareth L, Qin X, Muzny DM, Margulies M, Weinstock GM, Gibbs RA, Rothberg JM (2008) The complete genome of an individual by massively parallel DNA sequencing. Nature 452:872–876
Yeşin KB, Vollmers K, Nelson BJ (2006) Modeling and control of untethered biomicrorobots in a fluidic environment using electromagnetic fields. Int J Robotics Res 25:527–536
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Kurzweil, R., Grossman, T. (2010). Bridges to Life. In: Fahy, G.M., West, M.D., Coles, L.S., Harris, S.B. (eds) The Future of Aging. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3999-6_1
Download citation
DOI: https://doi.org/10.1007/978-90-481-3999-6_1
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-3998-9
Online ISBN: 978-90-481-3999-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)